UnitedHealth Group Incorporated (UNH · NYSE)

UNH · MARKET VIEW

Market view · as of Jul 6, 2026

Revenue (TTM)
$449.71B
+2.0% YoY
Gross margin
18.8%
EPS (latest q)
$7.23
vs $6.60 est · beat
52-wk position
98.7%
-0.6% vs 52w high · +13.5% 1mo

Price (last ~year)

UnitedHealth Group is trading at $425.36, near its 52-week high, following the recent decision to cover Guardant Health’s Shield colon cancer blood test for its members. For the quarter ending March 31, 2026, the company reported $111.72 billion in revenue and $6.28 billion in net income, beating earnings estimates with an EPS of $7.23. The firm, which holds a market capitalization of $386.29 billion, generated $8.15 billion in free cash flow during the same period while maintaining $28.00 billion in cash against $77.92 billion in total debt.

Valuation

Market cap
$386.29B
P/E
32.05
PEG
1.474
P/B
3.946
P/S
0.859
EV/EBITDA
18.96
Beta
0.633
Analyst target
$411.88

Quality & returns

Gross margin
18.8%
Operating margin
8.1%
Profit margin
2.7%
ROE
12.2%
ROA
3.8%

Price movement

Last
$425.36
1-month
+13.5%
3-month
+39.0%
RSI (14)
64
vs SMA200
+27.6%
52-wk position
98.7% -0.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$111.72B$8.99B$6.28B$10.09B
2025-12-31$113.22B$380.0M$10.0M$1.37B
2025-09-30$113.16B$4.32B$2.35B$5.33B
2025-06-30$111.62B$5.15B$3.41B$6.19B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots